Dupilumab for chronic spontaneous urticaria-marvelous or meek?
- PMID: 38754637
- DOI: 10.1016/j.jaci.2024.05.004
Dupilumab for chronic spontaneous urticaria-marvelous or meek?
Keywords: Urticaria; dupilumab; omalizumab.
Conflict of interest statement
Disclosure statement Disclosure of potential conflict of interest: S. K. Mathur received consulting and speaker fees from Astra-Zeneca, GSK, Sanofi, and Regeneron. D. L Rosenberg and R. K. Viswanathan report no conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
